A court ruling requires mifepristone to be distributed only in-person at clinics, overturning FDA regulations. The decision is expected to be appealed to the U.S. Supreme Court, potentially reshaping medication access policies.
Signal Search
Search across all ingested intelligence signals. Supports websearch syntax: AND OR "exact phrase" -exclude
87 results for "U.S." · Supply Chain+Health · Update
Page 1 of 4